Abbott's FreeStyle Libre 2 Receives Health Canada's Approval for Adults and Children with Diabetes
Shots:
- Abbott’s next-generation- sensor-based glucose monitoring technology- FreeStyle Libre 2- received Health Canada’s approval for adults & children with diabetes
- The system continuously measures glucose data every minute with customizable- optional real-time alarms to alert users when their glucose is high/low without scanning
- The technology sustains performance for ~14days- providing trends- insights & actionable data on a reader or with the FreeStyle LibreLink mobile app. FreeStyle Libre 2 will be available for people with diabetes aged ≥4yrs. in Canada in the coming months
Ref: PRNewswire | Image: Abbott
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com